Uncovering the substrate recognition mechanisms of the E3 ligase adaptor cereblon

揭示 E3 连接酶接头 cereblon 的底物识别机制

基本信息

  • 批准号:
    10685519
  • 负责人:
  • 金额:
    $ 32.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The immunomodulatory drugs thalidomide, lenalidomide, and pomalidomide exert their therapeutic effects by tailoring the substrate specificity of cereblon, a component of the ubiquitin proteasome system, resulting in altered substrate recruitment, ubiquitylation, and degradation. However, the native substrate specificity and biological functions of cereblon are elusive, despite the conservation of cereblon across species, its association with neurological development, and the potential impact that therapeutic engagement of cereblon would have on these substrates and pathways. To address the urgent need for better characterization of the native role cereblon plays in biological regulation, we undertook a novel approach to discover the substrate recognition mechanism of cereblon. We used a targeted protein degradation approach to systematically screen physiologically relevant ligands for functional engagement of cereblon in cells and discovered that we could replace thalidomide with peptides bearing a C-terminal glutarimide or aspartimide, which are post-translational modifications derived from cyclization of glutamine or asparagine, respectively. Endogenously, these C-terminal cyclic imides may act as molecular glues to recruit substrates to cereblon by tailoring substrate recognition, analogous to thalidomide, or may be generated directly on the substrate during protein aging and damage response or in response to signaling events. To address these two hypotheses, we will functionally characterize the recognition of these C-terminal cyclic imides by cereblon in cells in the context of two models: as peptide- based metabolites that alter substrate recognition or as part of a novel degron found at the C-terminus of proteins after protein aging or during a signaling event. We will first fully evaluate the recognition of peptide-based ligands in the context of bifunctional degraders for targeted protein degradation to characterize the scope and ligandability of cereblon by peptides and evaluate their ability to act as molecular glues for substrate recruitment in a manner analogous to thalidomide and lenalidomide. Next, we will assess whether C-terminal cyclic imides act as degrons that promote substrate recognition directly on engineered and endogenous proteins in biological systems. To facilitate the study of these modifications, we will develop orthogonal chemical labeling strategies to detect and map where and when these modifications occur in cells. Finally, we will investigate the formation of these modifications in cells to characterize the conditions, pathways, and “writers” that generate the C-terminal cyclic imides recognized by cereblon. The definition of C-terminal glutarimide and aspartimide modifications as the key recognition elements used to recruit endogenous substrates to cereblon and the associated studies constitutes a significant advance that will open new investigations into the biological regulation of proteins through these post-translational modifications and the effects on these pathways during cereblon engagement by small molecules, which will inform the use and development of therapeutics that engage cereblon in the clinic.
项目总结 免疫调节药物沙利度胺、来那度胺和泊马度胺通过 剪裁Cereblon的底物专一性,泛素蛋白酶体系统的一种成分,导致 改变底物募集、泛素化和降解。然而,天然底物的特异性和 尽管小脑蛋白在不同物种之间都是保守的,但它的生物学功能是难以捉摸的,它与 与神经发育的关系,以及参与治疗的雷伯龙的潜在影响 在这些底物和路径上。解决更好地描述本地角色的迫切需要 在生物调节中,我们采用了一种新的方法来发现底物识别。 脑波龙的作用机制。我们使用了有针对性的蛋白质降解方法来系统地筛选 与脑蛋白在细胞中的功能结合的生理相关的配体,并发现我们可以 用含有C-末端戊二酰亚胺或天冬氨酰亚胺的翻译后多肽取代沙利度胺 分别由谷氨酰胺或天冬酰胺环化而来的修饰。从内源性来看,这些C-末端 环酰亚胺可以作为分子胶通过调整底物识别来将底物招募到Cereblon上, 类似于沙利度胺,或在蛋白质老化和损伤过程中直接在底物上产生 响应或响应信号事件。为了解决这两个假设,我们将从功能上刻画 在两种模型的背景下,雷公藤多酚在细胞中识别这些C末端环酰亚胺:作为多肽- 改变底物识别的基本代谢物或作为蛋白质C末端发现的新降解子的一部分 在蛋白质老化之后或在信号事件期间。我们将首先全面评估基于多肽的配体的识别 在用于靶向蛋白质降解的双功能降解剂的背景下,以表征范围和 多肽与脑白蛋白的配基能力及其作为底物募集分子胶能力的评价 类似于沙利度胺和来那度胺。接下来,我们将评估C-末端环酰亚胺 在生物中作为降解物直接促进对工程蛋白和内源性蛋白的底物识别 系统。为了便于研究这些修饰,我们将开发正交化学标记策略 以检测和映射这些修改发生在单元格中的位置和时间。最后,我们将对形成进行调查 在细胞中的这些修饰,以表征产生C-末端的条件、途径和“写入者” 可被Cereblon识别的环酰亚胺。C-末端戊二酰亚胺和天冬氨酰亚胺修饰的定义为 脑白蛋白内源底物募集的关键识别元件及其相关研究 构成了一项重大进步,将开启蛋白质生物调节的新研究 通过这些翻译后修饰以及在小脑参与过程中对这些通路的影响 通过小分子,这将为临床上使用和开发使用小分子脑波龙的疗法提供信息。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular and Structural Characterization of Lenalidomide-Mediated Sequestration of eIF3i.
  • DOI:
    10.1021/acschembio.2c00706
  • 发表时间:
    2022-11-18
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Lin, Zhi;Shen, Dacheng;Yang, Bo;Woo, Christina M.
  • 通讯作者:
    Woo, Christina M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christina Woo其他文献

Christina Woo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christina Woo', 18)}}的其他基金

Writing and erasing O-GlcNAc on target proteins in the brain
在大脑中的目标蛋白上写入和擦除 O-GlcNAc
  • 批准号:
    10637668
  • 财政年份:
    2023
  • 资助金额:
    $ 32.84万
  • 项目类别:
Uncovering the substrate recognition mechanisms of the E3 ligase adaptor cereblon
揭示 E3 连接酶接头 cereblon 的底物识别机制
  • 批准号:
    10446251
  • 财政年份:
    2022
  • 资助金额:
    $ 32.84万
  • 项目类别:
Tools to facilitate manipulation of protein-specific glycosylation stoichiometry in cells
促进细胞中蛋白质特异性糖基化化学计量操作的工具
  • 批准号:
    10203887
  • 财政年份:
    2019
  • 资助金额:
    $ 32.84万
  • 项目类别:
Tools to facilitate manipulation of protein-specific glycosylation stoichiometry in cells
促进细胞中蛋白质特异性糖基化化学计量操作的工具
  • 批准号:
    9814357
  • 财政年份:
    2019
  • 资助金额:
    $ 32.84万
  • 项目类别:
Precision pharmacology of the opioids
阿片类药物的精准药理学
  • 批准号:
    9788392
  • 财政年份:
    2018
  • 资助金额:
    $ 32.84万
  • 项目类别:
Precision pharmacology of the opioids
阿片类药物的精准药理学
  • 批准号:
    10463709
  • 财政年份:
    2018
  • 资助金额:
    $ 32.84万
  • 项目类别:
Precision pharmacology of the opioids
阿片类药物的精准药理学
  • 批准号:
    10242770
  • 财政年份:
    2018
  • 资助金额:
    $ 32.84万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 32.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了